'They could see something happening'
In the 1980s and 1990s, Bangui, the republic's capital city, and its Institut Pasteur played a major role in HIV research. At the time, AIDS was poorly understood. “Medical staff at African hospitals could see something was happening, but nobody knew exactly what,” David recalled.
In 1985, leading global figures in the fight against AIDS met in Bangui to define clinical criteria, assigning a score to various symptoms. Bangui was an AIDS hot spot, and the city’s name became closely associated with the disease, not least because of this international gathering.
Back then, facing a health crisis when off-duty French soldiers who frequented African sex workers ending up contracting HIV, a push was made to get the soldiers and the women tested for the virus.
The Institut Pasteur in Bangui was tasked with administering the tests and monitoring the spread of the disease. But since the subjects were soldiers, the results were kept secret. “It was too politically sensitive,” David explained. “France didn’t want to publicize research on its soldiers.”
In 1989, a new project, code-named Operation Bangui, was launched, this time involving Central African soldiers.
“This secret study aimed to identify the viruses present in the military population, determine the prevalence and incidence of HIV, and eventually conduct a clinical trial of a vaccine,” David said. “This way, the French scientists were able to carry out their research undisturbed and had a competitive advantage over other scientists from the North, such as the Americans.”
The Central African authorities also wanted to keep the project under wraps. It meant they would be able to use the results of the research without the extent of the epidemic among their soldiers becoming public knowledge.
“They took advantage of the situation to administer important vaccines, such as the one against yellow fever, which led people to conflate the two,” David said.